Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

MUC1, a therapeutic vaccine, is a transmembrane glycoprotein and a member of the mucin family of molecules.

A synthetic dsRNA viral mimic and host-defense activator, mimics nature by combining the essential elements of human immunity.

A type of hormone therapy for cancer used to inhibit aromatase to treat a hormone-related breast cancer.